Shinhan Financial Group Co Ltd (SHG) 35.76 $SHG Royal

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Shinhan Financial Group Co Ltd (SHG) 35.76 $SHG

Royal Bank of Canada Looks to Expand Organically in U.S.
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 1:49PM CDT
Following the stock-cash merger deal worth $5 billion of Toronto-based Royal Bank of Canada (RY) and U.S.-based City National Corporation in Nov 2015, Royal Bank of Canada's Chief Executive Dave McKay intends further expansion in the United States.
RY: 60.00 (-0.28), CM: 74.46 (-0.51), BBVA: 5.40 (-0.18), SHG: 35.76 (-0.37)

Banco Macro (BMA) in Focus: Stock Moves 5.9% Higher
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:45AM CDT
Banco Macro S.A. (BMA) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
BMA: 72.09 (-0.56), SHG: 35.76 (-0.37)

Zacks Industry Outlook Highlights: BBVA Banco Francés, Deutsche Bank, UBS Group, Royal Bank of Canada and Shinhan Financial Group
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 8:30AM CDT
Zacks Industry Outlook Highlights: BBVA Banco Francés, Deutsche Bank, UBS Group, Royal Bank of Canada and Shinhan Financial Group
BFR: 19.41 (-0.32), RY: 60.00 (-0.28), DB: 12.58 (-0.49), UBS: 12.97 (-0.52), SHG: 35.76 (-0.37)

Foreign Banks Stock Outlook - June 2016
Kalyan Nandy - Zacks Investment Research - Thu Jun 09, 4:30PM CDT
Foreign Banks Stock Outlook - June 2016
BCS: 7.84 (-0.15), TD: 42.88 (-0.40), BFR: 19.41 (-0.32), CS: 10.81 (-0.53), RY: 60.00 (-0.28), DB: 12.58 (-0.49), HSBC: 32.16 (-0.10), UBS: 12.97 (-0.52), CM: 74.46 (-0.51), SHG: 35.76 (-0.37)

Deutsche Bank's Postbank IPO on Hold, Seeks "Creative" Exit
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 8:34AM CDT
In a bid to boost capital levels, Deutsche Bank AG's (DB) efforts to deconsolidate its retail unit, Deutsche Postbank AG, seem to get further delayed
BMO: 63.11 (-0.27), DB: 12.58 (-0.49), CM: 74.46 (-0.51), SHG: 35.76 (-0.37)

Deutsche Bank (DB) Ratings Cut by Moody's; Outlook Stable
Zacks Equity Research - Zacks Investment Research - Thu May 26, 6:56AM CDT
Moody's Investors Service, a rating arm of Moody's Corporation (MCO), recently concluded the review of Deutsche Bank AG (DB) and its subsidiaries' for a possible rating downgrade.
DB: 12.58 (-0.49), CM: 74.46 (-0.51), SHG: 35.76 (-0.37), MCO: 104.19 (-1.08)

Nomura Holdings (NMR) Slashes Executive Pay by 18%
Zacks Equity Research - Zacks Investment Research - Wed May 25, 6:35AM CDT
Japanese brokerage giant Nomura Holdings, Inc. (NMR) has reportedly cut pay for its top executives by 18% as the company struggled with a plunge in profits.
NMR: 4.18 (-0.11), CM: 74.46 (-0.51), SHG: 35.76 (-0.37)

Deutsche Bank Examines Trades that May Have Cost it $60M
Zacks Equity Research - Zacks Investment Research - Fri May 20, 7:59AM CDT
Deutsche Bank AG (DB) is conducting an internal probe into certain trades commenced in 2009 that may have benefited a group of current and former employees with substantial profits, some of it at the bank's expense
DB: 12.58 (-0.49), CM: 74.46 (-0.51), SHG: 35.76 (-0.37)

Barclays Africa Attracts Bid from Abraaj for Stake Sale
Zacks Equity Research - Zacks Investment Research - Mon May 16, 9:04AM CDT
Barclays Africa unit has attracted the attention of Abraaj. The private equity firm plans to acquire a minority stake in the division.
BCS: 7.84 (-0.15), CG: 16.81 (-0.26), GGAL: 28.74 (-0.40), SHG: 35.76 (-0.37)

Mitsubishi UFJ & Hitachi Form Capital and Business Tie-up
Zacks Equity Research - Zacks Investment Research - Mon May 16, 8:56AM CDT
Japanese banking giant Mitsubishi UFJ Financial Group, Inc. (MTU) and Hitachi, Ltd. have entered into a business alliance to boost their operations
MTU: 4.94 (-0.23), GGAL: 28.74 (-0.40), SHG: 35.76 (-0.37)

UBS Seeks Dismissal of Claims Tied with MBS Lawsuit
Zacks Equity Research - Zacks Investment Research - Mon May 16, 8:48AM CDT
BS Group AG (UBS) has urged a U.S. judge to dismiss claims that the bank should be held liable for losses of $2 billion incurred by investors on mortgage-backed securities (MBS)
GGAL: 28.74 (-0.40), UBS: 12.97 (-0.52), SHG: 35.76 (-0.37)

Deutsche Bank (DB) Being Probed on 2011 Italian Bond Sale
Zacks Equity Research - Zacks Investment Research - Tue May 10, 9:02AM CDT
Deutsche Bank AG (DB) is under investigation by Italian authorities related to the bank's sale of 7 billion euro ($8 billion) of Italian government bonds in 2011.
BMA: 72.09 (-0.56), DB: 12.58 (-0.49), GGAL: 28.74 (-0.40), SHG: 35.76 (-0.37)

Barclays (BCS) Sells 12% Stake in Africa Unit: Now What?
Zacks Equity Research - Zacks Investment Research - Mon May 09, 9:53AM CDT
Barclays began offloading stake in Africa unit. Will the company continue stake sale through capital markets or seek a strategic buyer for the remaining interest?
BCS: 7.84 (-0.15), CG: 16.81 (-0.26), GGAL: 28.74 (-0.40), SHG: 35.76 (-0.37)

Deutsche Bank Warned by FCA Over 'Serious' Control Issues
Zacks Equity Research - Zacks Investment Research - Tue May 03, 3:58PM CDT
Deutsche Bank AG (DB) has "serious" failings in anti money laundering controls, per findings by the UK regulator Financial Conduct Authority (FCA).
BMA: 72.09 (-0.56), DB: 12.58 (-0.49), GGAL: 28.74 (-0.40), SHG: 35.76 (-0.37)

5 Stocks with Impressive Price-to-Sales Ratio
Zacks Equity Research - Zacks Investment Research - Tue Apr 26, 2:04PM CDT
Price-to-Sales is used to identify recovery situations or to ensure that a company's growth has not become overvalued.
MN: 7.82 (+0.09), SAFM: 88.23 (+0.08), KBH: 15.41 (-0.31), PKX: 49.90 (-0.58), SHG: 35.76 (-0.37)

Mitsubishi UFJ Plans Further Expansion in U.S. and Asia
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 10:30AM CDT
Japanese banking giant Mitsubishi UFJ Financial Group, Inc.,'s (MTU) core unit is contemplating further acquisitions in the U.S. and Asia, in line with its strategy to pursue global growth opportunities
MTU: 4.94 (-0.23), GGAL: 28.74 (-0.40), MS: 28.00 (-0.50), SHG: 35.76 (-0.37)

Deutsche Bank (DB) Under Review for Downgrade by Moody's
Zacks Equity Research - Zacks Investment Research - Wed Mar 23, 3:00PM CDT
The ratings of Deutsche Bank AG (DB) along with its subsidiaries have been kept under review for a possible downgrade by Moody's Investors Service, a rating arm of Moody's Corporation (MCO).
DB: 12.58 (-0.49), GGAL: 28.74 (-0.40), SHG: 35.76 (-0.37), MCO: 104.19 (-1.08)

Deutsche Bank (DB) Trims Retail Outlets in Germany
Zacks Equity Research - Zacks Investment Research - Mon Mar 21, 3:44PM CDT
Deutsche Bank AG (DB) is cutting down its network of retail outlets in Germany from over 700 to 500, as part of its digitization and cost reduction measures.
DB: 12.58 (-0.49), GGAL: 28.74 (-0.40), CM: 74.46 (-0.51), SHG: 35.76 (-0.37)

Zacks Industry Outlook Highlights: Itaú Unibanco Holding S.A., Banco Santander-Chile, Shinhan Financial Group, Mizuho Financial Group and Nordea Bank AB
Zacks Equity Research - Zacks Investment Research - Thu Feb 04, 8:30AM CST
Zacks Industry Outlook Highlights: Itaú Unibanco Holding S.A., Banco Santander-Chile, Shinhan Financial Group, Mizuho Financial Group and Nordea Bank AB
MFG: 3.20 (-0.08), BSAC: 20.59 (-0.03), ITUB: 10.36 (+0.11), SHG: 35.76 (-0.37)

Foreign Banks Stock Outlook - Feb. 2016
Kalyan Nandy - Zacks Investment Research - Wed Feb 03, 12:25PM CST
Foreign Banks Stock Outlook - Feb. 2016
MFG: 3.20 (-0.08), CS: 10.81 (-0.53), BSAC: 20.59 (-0.03), HSBC: 32.16 (-0.10), CM: 74.46 (-0.51), CIB: 33.72 (+0.21), ITUB: 10.36 (+0.11), SHG: 35.76 (-0.37)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 26

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading

Top 5 Most Recently Viewed Articles

NuCana Discontinues Phase 2 Colorectal Cancer Study

Updated Category News Views 146

NuCana Provides Update on Phase 2 Randomized Colorectal Cancer Study NuTide:323 Study Discontinued Following Initial Analysis Ongoing Studies Show Promise with NUC-7738 and Pembrolizumab NuCana plc (NASDAQ: NCNA) has shared important updates about its clinical trials focused on innovative treatments for colorectal cancer. The company has made the decision to discontinue...

Continue Reading
Brøndbyernes IF Football Meeting - Key Highlights Recap

Updated Category News Views 179

Overview of the Annual General Meeting for Brøndbyernes IF Football A/S BRØNDBYERNES I.F. FODBOLD A/S CVR-nr. 83 93 34 10 This report summarizes the outcomes of the annual general meeting conducted by Brøndbyernes IF Football A/S. Key Date and Location The annual shareholders meeting took place, gathering stakeholders and shareholders at the club's headquarters. A...

Continue Reading
Uncovering the Wealth from Investing in BlackRock

Updated Category News Views 314

The Potential Growth of $1000 in BlackRock Investors often wonder how their money would grow over time if invested in strong companies. Recently, we looked into BlackRock, Inc., known by its stock ticker BLK. Over a span of 15 years, investing just $1000 into BlackRock stocks would yield an impressive value today. According to current evaluations, if you had made that...

Continue Reading
Zealand Pharma Advances Glepaglutide Approval for SBS Treatment

Updated Category News Views 267

Glepaglutide Submission to EMA Marks Significant Progress Zealand Pharma A/S, a pioneering biotechnology company, has recently shared exciting news about its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for its innovative drug, glepaglutide. This long-acting GLP-2 analog is specifically designed for treating adults suffering from short...

Continue Reading
Seven Gables Real Estate Partners with Local Logic for Insights

Updated Category News Views 40

Seven Gables Real Estate Partners with Local Logic In a significant move that underscores their dedication to innovation, Seven Gables Real Estate has announced an exciting partnership with Local Logic, a leader in location intelligence. This collaboration is set to incorporate Local Logic's cutting-edge products—Local Content, Local Search, and NeighborhoodWrap—into...

Continue Reading